Oncolytic vaccines increase the response to PD-L1 blockade in immunogenic and poorly immunogenic tumors

DOI: 10.1080/2162402X.2018.1457596

Keywords: breast cancer, cancer epitopes, cancer vaccines, checkpoint inhibitors, immunotherapy, melanoma, oncolytic vaccines, oncolytic viruses, therapeutic antibodies, therapeutic vaccination

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text